Acro Biomedical (ACBM) Current Assets (2015 - 2025)
Acro Biomedical's quarterly Current Assets came in at $14098.0 in Q4 2025, up 177.74% year-on-year from $5076.0 in Q4 2024, and up 226.12% quarter-over-quarter from $4323.0 in Q3 2025.
Acro Biomedical has reported Current Assets for 11 years, with the latest figure at $14098.0 in Q4 2025.
- For the quarter ending Q4 2025, Current Assets rose 177.74% year-over-year to $14098.0; the trailing twelve-month figure through Dec 2025 stood at $14098.0 (up 177.74% YoY), and the FY2025 full-year result was $14098.0, up 177.74% from the prior year.
- Current Assets for Q4 2025 stood at $14098.0, up from $4323.0 in the prior quarter.
- The five-year high for Current Assets was $920256.0 in Q1 2021, with the low at $151.0 in Q1 2024.
- Average Current Assets over 5 years is $337879.9, with a median of $282893.0 recorded in 2023.
- Year-over-year, Current Assets slumped 99.98% in 2024 and soared 4179.27% in 2025.
- Tracing ACBM's Current Assets over 5 years: stood at $706415.0 in 2021, then declined by 6.92% to $657537.0 in 2022, then tumbled by 99.75% to $1626.0 in 2023, then surged by 212.18% to $5076.0 in 2024, then jumped by 177.74% to $14098.0 in 2025.
- The last three Current Assets figures came in at $14098.0 (Q4 2025), $4323.0 (Q3 2025), and $39626.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 1.58 Mn |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | 405,162.00 |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | 54,530.00 |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | 280,749.00 |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | 214,543.00 |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | 595,733.00 |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | 665,298.00 |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | 509,350.00 |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | 888,171.00 |
| 10 | Acro Biomedical | - | - | - | 14,098.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14,098.00 |
| Sep 30, 2025 | 4,323.00 |
| Jun 30, 2025 | 39,626.00 |
| Mar 31, 2025 | 4,851.00 |
| Dec 31, 2024 | 5,076.00 |
| Sep 30, 2024 | 701.00 |
| Jun 30, 2024 | 926.00 |
| Mar 31, 2024 | 151.00 |
| Dec 31, 2023 | 1,626.00 |
| Sep 30, 2023 | 12,501.00 |
| Jun 30, 2023 | 526,160.00 |
| Mar 31, 2023 | 637,552.00 |
| Dec 31, 2022 | 657,537.00 |
| Sep 30, 2022 | 607,428.00 |
| Jun 30, 2022 | 626,902.00 |
| Mar 31, 2022 | 680,018.00 |
| Dec 31, 2021 | 706,415.00 |
| Sep 30, 2021 | 623,560.00 |
| Jun 30, 2021 | 687,891.00 |
| Mar 31, 2021 | 920,256.00 |
| Dec 30, 2020 | 973,353.00 |
| Sep 30, 2020 | 954,156.00 |
| Jun 30, 2020 | 957,381.00 |
| Mar 31, 2020 | 972,636.00 |
| Dec 31, 2019 | 879,471.00 |
| Sep 30, 2019 | 1.07 Mn |
| Jun 30, 2019 | 1.07 Mn |
| Mar 31, 2019 | 1.07 Mn |
| Dec 31, 2018 | 1.25 Mn |
| Sep 30, 2018 | 1.48 Mn |
| Jun 30, 2018 | 1.01 Mn |
| Mar 31, 2018 | 862,931.00 |
| Dec 31, 2017 | 759,542.00 |
| Sep 30, 2017 | 548,310.00 |
| Jun 30, 2017 | 2,500.00 |
| Mar 31, 2017 | 2,000.00 |
| Dec 31, 2016 | 2,391.00 |
| Sep 30, 2016 | 2,533.00 |
| Jun 30, 2016 | 2,341.00 |
| Mar 31, 2016 | 11,742.00 |
| Sep 30, 2015 | 29,460.00 |